Products for Research Use Only
RegisterLogin

Rebastinib (DCC-2036)

CAT: 0957-S2634-01Size: 10 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0957-S2634-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Rebastinib (DCC-2036) is a conformational control Bcr-Abl inhibitor for Abl1 (WT) and Abl1 (T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.
CAS Number
1020172-07-9
Target
Bcr-Abl
Activity
Protein Tyrosine Kinase
Molecular Formula
C30H28FN7O3
Storage Conditions
2 years -80 in solvent

Related Products

CatalogName
E1954-01DCC-3116
E1954-100mgDCC-3116
E1954-5mgDCC-3116
E1954-1gDCC-3116
E1954-25mgDCC-3116
PA1910Anti-Netrin receptor DCC DCC Antibody Picoband®
A00560Anti-DCC Antibody Picoband®
EK2184Mouse/Rat DCC ELISA Kit PicoKine®
E0499-014SC-203
S8882-25mgODM-203

Alternative Products

CatalogName
B1404-50DCC-2036 (Rebastinib)
C08739-10mgRebastinib (DCC-2036)
MBS130966-01DCC-2036(Rebastinib)
A11200-2DCC-2036 (Rebastinib) 2mg
A11200-200DCC-2036 (Rebastinib) 200mg
A11200-25DCC-2036 (Rebastinib) 25mg
FD64998-01DCC 2036
GTR19164069-01DCC-2036

Popular Products